V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206744 | 20077331 | 1.91 | 62.6 | Palliative (P) | 2017-07-04 | 2017-07-09 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101543682 |
| 20206745 | 20077332 | 1.73 | 68.8 | Palliative (P) | 2017-01-12 | 2017-01-14 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100947851 |
| 20206746 | 20077333 | 1.57 | 69.3 | Adjuvant (A) | 2018-06-07 | 2018-06-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101251309 |
| 20206751 | 20077334 | 1.76 | 81 | Neo-adjuvant (N) | 2018-01-01 | 2018-01-14 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 100771397 |
| 20206753 | 20077335 | 1.67 | 58.9 | Palliative (P) | 2019-03-14 | 2019-04-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100255464 |
| 20206758 | 20077336 | 1.58 | 75.6 | Palliative (P) | 2020-02-10 | 2020-02-10 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100848698 |
| 20206759 | 20077337 | 1.48 | 80.65 | Curative (C) | 2017-06-11 | 2017-06-18 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 100645056 |
| 20206761 | 20077338 | 1.69 | 80 | Palliative (P) | 2017-11-05 | 2017-11-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100185887 |
| 20206764 | 20077339 | 1.7 | 81.6 | Palliative (P) | 2017-01-09 | 2017-01-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100918720 |
| 20206765 | 20077340 | 1.64 | 57.3 | Palliative (P) | 2017-05-01 | 2017-05-01 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101769235 |
| 20206766 | 20077341 | 1.88 | 81.9 | Neo-adjuvant (N) | 2018-09-15 | 2018-09-28 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101324144 |
| 20206767 | 20077342 | 1.68 | 101.7 | Neo-adjuvant (N) | 2017-08-24 | 2017-09-04 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101251916 |
| 20206768 | 20077343 | 1.64 | 66.7 | Palliative (P) | 2018-07-21 | 2018-08-10 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100070340 |
| 20206772 | 20077344 | 1.77 | 93.8 | Curative (C) | null | 2016-05-20 | CAPECITABINE + CARBOPLATIN | 02 | Y | CISPLATIN + FLUOROURACIL | 101145590 |
| 20206775 | 20077345 | 1.5 | 93 | Palliative (P) | 2016-12-06 | 2016-12-16 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100846262 |
| 20206781 | 20077346 | 0 | 0 | Palliative (P) | 2019-01-09 | 2019-01-09 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100013291 |
| 20206785 | 20077347 | 1.65 | 105.05 | null | 2018-11-05 | 2018-11-05 | Cisplatin + Modified de Gramont | 02 | N | CISPLATIN + FLUOROURACIL | 101735435 |
| 20206787 | 20077348 | 1.7 | null | Neo-adjuvant (N) | 2017-09-18 | 2017-09-18 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101189410 |
| 20206793 | 20077349 | 1.67 | 61.1 | Palliative (P) | 2016-01-20 | 2016-01-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101703846 |
| 20206801 | 20077350 | 1.73 | 74.6 | Neo-adjuvant (N) | 2018-10-23 | 2018-10-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100462107 |
| 20206805 | 20077351 | 0 | 0 | Palliative (P) | 2018-05-28 | 2018-06-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100351629 |
| 20206811 | 20077352 | 1.52 | 104 | Palliative (P) | 2019-05-05 | 2019-05-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101272488 |
| 20206819 | 20077353 | 1.57 | 55 | null | 2017-12-23 | 2017-12-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101834207 |
| 20206822 | 20077354 | 1.57 | null | Neo-adjuvant (N) | 2017-08-12 | 2017-09-04 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101252810 |
| 20206823 | 20077355 | 1.74 | 57.1 | null | 2019-06-24 | 2019-07-22 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101610179 |
| 20206825 | 20077356 | 1.69 | 0 | Neo-adjuvant (N) | 2019-02-07 | 2019-02-24 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101413407 |
| 20206831 | 20077357 | 1.59 | 78.1 | 03 | null | 2016-06-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100599687 |
| 20206836 | 20077358 | 1.55 | 57.1 | Palliative (P) | 2018-04-13 | 2018-04-21 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 100185289 |
| 20206842 | 20077359 | 1.82 | 70 | Palliative (P) | 2019-08-31 | 2019-08-31 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101536746 |
| 20206845 | 20077360 | 1.95 | 63.2 | Palliative (P) | 2018-11-06 | 2018-11-15 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100278561 |
| 20206848 | 20077361 | 1.66 | 64 | Palliative (P) | 2017-11-23 | 2017-12-02 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100260014 |
| 20206851 | 20077362 | null | null | Palliative (P) | 2017-03-23 | 2017-04-26 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100433479 |
| 20206856 | 20077363 | 0 | 0 | Palliative (P) | 2016-09-25 | 2016-10-16 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100953191 |
| 20206862 | 20077364 | 1.66 | 79.5 | Curative (C) | 2018-04-11 | 2018-04-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100298162 |
| 20206863 | 20077365 | 1.7 | 61.35 | null | 2017-03-02 | 2017-03-07 | Capecitabine (21days) + Carboplatin | 02 | null | TRIAL UNSPECIFIED | 100139112 |
| 20206865 | 20077366 | 1.78 | 74 | Neo-adjuvant (N) | 2017-09-02 | 2017-09-23 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100291331 |
| 20206867 | 20077367 | 1.74 | null | Curative (C) | 2018-08-25 | 2018-09-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100485865 |
| 20206868 | 20077368 | 1.73 | 65 | Neo-adjuvant (N) | 2019-05-02 | 2019-05-16 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100877971 |
| 20206870 | 20077369 | 1.78 | 79.3 | Neo-adjuvant (N) | 2017-09-13 | 2017-09-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100003983 |
| 20206872 | 20077370 | 1.7 | 49.5 | Palliative (P) | 2016-12-13 | 2016-12-23 | Capecitabine (21days) + Carboplatin | N | null | CISPLATIN + FLUOROURACIL | 100848623 |
| 20206874 | 20077371 | 1.84 | 75.2 | Neo-adjuvant (N) | 2016-11-26 | 2016-11-29 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100464468 |
| 20206879 | 20077372 | 1.7 | 90.6 | null | 2017-02-11 | 2017-02-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101204121 |
| 20206881 | 20077373 | 1.68 | 77 | Palliative (P) | 2019-04-10 | 2019-04-23 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100219287 |
| 20206884 | 20077374 | 1.71 | 46.8 | Curative (C) | 2019-03-02 | 2019-03-17 | CAPECITABINE + CARBOPLATIN | 02 | Y | CISPLATIN + FLUOROURACIL | 100002994 |
| 20206886 | 20077375 | 1.7 | 64.75 | Curative (C) | 2017-01-20 | 2017-02-17 | Doxorubicin chemoembolisation | null | Y | DOXORUBICIN EMBOLISATION | 100381918 |
| 20206890 | 20077376 | 0 | 0 | Palliative (P) | 2018-01-18 | 2018-01-27 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100839023 |
| 20206891 | 20077377 | 1.55 | 85 | Palliative (P) | 2020-01-24 | 2020-01-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100066864 |
| 20206892 | 20077378 | 1.57 | 47.4 | Curative (C) | 2016-11-19 | 2016-11-26 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100758012 |
| 20206895 | 20077379 | 1.78 | 92.2 | Palliative (P) | 2017-04-26 | 2017-04-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100846001 |
| 20206897 | 20077380 | 1.52 | 86.6 | Curative (C) | 2019-03-13 | 2019-03-13 | CAPECITABINE + CARBOPLATIN | null | N | CISPLATIN + FLUOROURACIL | 100668869 |